Jul 29, 2021· Comment from Medical Imaging & Technology Alliance (MITA)· FDA-2011-D-0514-0020
Filed on regulations.gov — full text not in the inline record.
Medical Imaging & Technology Alliance filed 2 comments on this docket between Dec 9, 2011 and Jul 29, 2021. 1 other organizations filed here. The comment window closed 1828d ago.
Filed on regulations.gov — full text not in the inline record.
Dear Sir/Madam: RE: FDA-2011-D-0514 Attached please find comments of the Medical Imaging & Technology Alliance (MITA) in response to the draft guidance, as announced in 76 Federal Register 50740, August 16, 2011, "Procedures for Handling Section 522 Postmarket Surveillance Studies." If you have any questions, please contact me at 703 841 - 3248 or by email at reaton@medicalimaging.org. Sincerely, Richard M. Eaton, Industry Manager, Medical Imaging & Technology Alliance (MITA)
Status: OPEN
View on regulations.gov →